Implementation of R&D work on innovative technology for chemical synthesis of vitamin K2(MK-7))

The beneficiary, VitaSynth Sp. z o.o., is implementing the project titled "Implementation of R&D work on innovative technology for chemical synthesis of vitamin K2(MK-7)”
As part of the Regional Operational Program of the Mazovian Voivodeship 2014-2020 (ROP WM 2014-2020). AXIS III Development of innovation potential and entrepreneurship. Measure: 3.3 Innovation in SMEs.
Intake number:RPMA.03.03.00-IP.01-14-122/22


The aim of the project is to launch a new product with increased purity on the market by using the results of R&D work carried out in-house. Implementation of the project is the result of own R&D work on the development of chemical synthesis of vitamin K2 (MK7). The project uses the effects of another project for which the Applicant received a grant under the WM ROP 2014-2020 Measure 1.2 Research and development activities of enterprises" (conducting R&D work). Implementation of the project will have a positive impact on the Company's employment policy and the environment. As a result of the project, the Company will implement an innovative solution on the market, thereby increasing its competitiveness and acquiring new customers.

Total value of the project: 708 610,00 PLN
Amount of eligible expenditure: 707 000,00 PLN

Grant amount: 565 600,00 PLN
‍
Project implementation date: 01-04-2023 – 31.12.2023

​​​www.mapadotacji.gov.pl

Project Co-financed by the European Union from the ERDF under the RDP of Mazowieckie Voivodeship for 2014-2020.Priority axis III Development of innovation potential and entrepreneurship - Measure 3.3 Innovation in SMEs, type of projects: Launching new or improved products or services on the market.

‍
The beneficiary, VitaSynth Sp. z o.o., is implementing the project entitled "Use of the results of R&D work carried out as an opportunity to increase the competitiveness of the Company on the international market".
As part of the Regional Operational Program of the Mazovian Voivodeship 2014-2020 (ROP WM 2014-2020). AXIS III Development of innovation potential and entrepreneurship. Measure: 3.3 Innovation in SMEs.
Intake number: RPMA.03.03.00-IP.01-14-117/21
‍
The aim of the project is to implement an innovative technology on the market, by using the results of R&D work carried out in-house.
‍
The project plans to use the results of R&D work carried out in-house, thanks to which the Company is now in possession of an innovative technology ready for commercialization. The technology has been independently developed by the R&D department. It uses the effects of another project for which the Applicant received a grant under the WM ROP 2014-2020 Measure 1.2 "Creation or development of research and development facilities". In addition, further development work was also carried out on the infrastructure for which the Applicant received a grant under the said measure. The implementation of the project will have a positive impact on the Company's employment policy and the environment. As a result of the project, the Company will implement an innovative solution on the market, thanks to which it will increase its competitiveness and acquire new customers. The aim of the project is to create the necessary infrastructure to introduce new products to the sales offer. The scope of the project includes the implementation of a total of 4 tasks consisting of: preparatory work, purchase of fixed assets, construction works and costs related to promotion. The main objective of the project is to increase the competitiveness of the applicant on the domestic and international market, thanks to the implementation of innovative solutions. The target group of the project will be mainly consumers and manufacturers in the market of dietary supplements, foodstuffs for special nutritional purposes and functional food. Phase 1 involves work


Total value of the project: 15 924 013,50 PLN
Amount of eligible expenditure: 3 553 824,35 PLN
Grant amount: 1 072 647,30 PLN


​​​www.mapadotacji.gov.pl